Document is current
Any future updates will be listed below
-
Authors
Melchior, Thomas Maria
Kelbæk, Henning
Olsen, Michael Hecht
Melchior, Simon Emil
Munch, Michael
Kjøller-Hansen, Lars
- License Information
-
More Information
Article History
Received: 14 January 2025
Accepted: 25 July 2025
First Online: 9 October 2025
Declarations
:
: RDN treatment was implemented as a routine treatment option in Denmark in 2011–12 for patients with treatment-resistant hypertension. All patients were thoroughly instructed and gave informed consent for RDN treatment in accordance with the Declaration of Helsinki. The current data were collected as part of a national report (Medical Technology Assessment (MTA), and all patient-identifiable fields were removed before analysis. According to our local authorities, such a report did not require approval by our ethics committee. Data are placed on a secure server in accordance with GDPR (General Data Protection Regulation) legislation applicable in Denmark.
: Not applicable.
: The authors declare no competing interests.
